Resource Center Access industry insights and real-world results. Advancing Inclusive Clinical Research for Rare DiseasesIn this engaging interview, Ariel Katz, CEO and Co-founder at H1, sat down with Pam Fearon, Vice President of Global Study Operations at BioMarin, to discuss how the company… Continue reading → Read the article Read the latest perspectives from our team of subject matter experts. Go to BlogResource Types:Case Studies Customer Stories Executive Briefs Infographics Perspectives Podcasts Resource Guides Videos Webinars White Papers Resource Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Resource Industries:Commercialization Payors Pharmaceutical & Biotechnology Provider Data White Papers2024 Report: The State of Diversity and Equity in Clinical Trials White PapersRedefining Pharmaceutical Success White PapersEquity and Ethics – AI and Drug Development White PapersThe Role of RWE in Clinical Trial Site Selection White PapersHow AI Can Save Medical Affairs from Drowning in Data White PapersIndustry Report: The State of Diversity and Equity in Clinical Trials White PapersHealth Equity Starts with Pharma Thought Leaders White PapersPast the Podium: A New Tech Stack for Medical Affairs White PapersBuilding Trust and Inclusion for Equitable and Diverse Clinical Trials White PapersThe Evolution of D&I in Clinical Trials White PapersThe Role of SDOH in Improving Patient Outcomes Through Clinical Trials White PapersTop 4 Challenges in KOL Engagement